
Caroline Catherman
Health Reporter at Morning Brew
@MorningBrew health reporter. Past: @OrlandoSentinel, @CNN. Alumna @EmoryUniversity, @MedillSchool. [email protected] || 🏳️🌈
Articles
-
1 week ago |
healthcare-brew.com | Caroline Catherman
Are you curious about all the ways that multimillion-dollar medtech can go wrong? If so, you’re in the right place!Welcome to Recall Roundup, a noncomprehensive roundup of recent FDA Class I recalls—the most severe and potentially life-threatening kind. Recalls range from correcting an issue to removing a device from the market altogether. With that, let’s get into it!Blood products administration set recall.
-
1 week ago |
healthcare-brew.com | Caroline Catherman
Welcome to June’s On Rotation!Each month, we highlight some of the major job changes in the healthcare sector, from small startups bringing in new leadership to big orgs trading seasoned execs. Here’s a noncomprehensive roundup of the past month’s career shifts. Have a job announcement to share? Drop Caroline an email at .
-
1 week ago |
healthcare-brew.com | Caroline Catherman
This year has been a rollercoaster for the pharmaceutical industry, and at this point, it’s unclear whether the ride is about to stop or if we’re at the top of another drop. The industry overall has posted mixed earnings so far, with companies performing better than expected in some categories but falling short in others, Healthcare Brew previously reported.
-
1 week ago |
healthcare-brew.com | Caroline Catherman
Hospitals and third-party companies have long been cleaning, retesting, and reusing medical devices, including those labeled as single-use, an approach known as “reprocessing.”Often, this can help cut down medical waste and save money, and it doesn’t appear to compromise safety: As of 2000, the FDA requires reprocessed devices to meet the same formal regulatory standards of the original products, including premarket testing.
-
2 weeks ago |
healthcare-brew.com | Caroline Catherman
With tariffs on the way “very shortly” for imported drugs, pharma giants like and Johnson & Johnson are investing billions into expanding US manufacturing. On the surface, it seems like tariffs are accomplishing the promised goal of bringing manufacturing back to the US.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 806
- Tweets
- 1K
- DMs Open
- Yes

RT @jeffschweers: Why not respond to my numerous public records requests?

For those who have never heard of "free kill," it's a fascinating law. A repeal was recently vetoed by Gov. DeSantis. https://t.co/JUuzmvv4Oy

RT @BrettMmurphy: NEW: Internal State Department records show that months of warnings have become a reality: The Trump administration’s sud…